Showing results (231-240 of 1,028) with videos related to

Sort By:
Pageof 103
The Lancet. Respiratory Medicine|March 19, 2026
Epidemiology, ventilation, and outcomes of acute respiratory failure in immunocompromised patients from 103 intensive care units in 26 countries: a retrospective observational studyElie Azoulay, Colleen McEvoy, Pedro Castro, et al.
The Lancet. Respiratory Medicine|May 11, 2024
Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studiesLeonardo Martinez, James A Seddon, C Robert Horsburgh, et al.
The Lancet. Respiratory Medicine|May 3, 2024
Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trialMatthew F Mart, Leanne M Boehm, Amy L Kiehl, et al.
The Lancet. Respiratory Medicine|September 13, 2023
Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trialGöran Dellgren, Thomas Kromann Lund, Peter Raivio, et al.
The Lancet. Respiratory Medicine|September 3, 2023
Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trialFelix C Ringshausen, Adam J Shapiro, Kim G Nielsen, et al.
The Lancet. Respiratory Medicine|April 5, 2026
Rilzabrutinib for patients with moderate-to-severe asthma with uncontrolled symptoms: a double-blind, placebo-controlled, phase 2 studyJorge F Maspero, Ian D Pavord, Michael E Wechsler, et al.
The Lancet. Respiratory Medicine|May 12, 2026
Oxygen saturation thresholds in children with acute respiratory distress (OxyKids): a multicentre, open, parallel-group, randomised clinical trialSam Louman, Karlijn J van Stralen, Gerard H Koppelman, et al.
The Lancet. Respiratory Medicine|May 19, 2026
Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registriesRebecca C Hull, Yang Liu, Zu Cao, et al.
The Lancet. Respiratory Medicine|May 18, 2026
Efficacy and safety of tezepelumab versus placebo in reducing oral corticosteroid use in adults with severe, oral corticosteroid-dependent asthma (SUNRISE): a multicentre, placebo-controlled, double-blind, phase 3 trialMichael E Wechsler, Christopher E Brightling, Guy Brusselle, et al.
The Lancet. Respiratory Medicine|May 4, 2026
Epidemiology, ventilation management, and clinical outcomes in children (PRoVENT-PED): first results from the 10-year, investigator-initiated, international, multicentre, prospective cohort studyRelin van Vliet, Jonathan W J Melger, Reinout A Bem, et al.
Pageof 103